XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 1,566 $ 326 $ 2,075 $ 629
Selling, general and administrative 1,085 1,049 3,463 2,951
Total operating expenses 2,651 1,375 5,538 3,580
Operating loss (2,651) (1,375) (5,538) (3,580)
Other income, net:        
Sublease income 32 61
Other income (expense), net 37 (2) 34 (3)
Total other income, net 37 30 34 58
Net loss (2,614) (1,345) (5,504) (3,522)
Preferred stock dividends 3 (18) (77) (18)
Net loss attributable to common stockholders $ (2,611) $ (1,363) $ (5,581) $ (3,540)
Basic net loss per share $ (0.19) $ (0.12) $ (0.43) $ (0.32)
Diluted net loss per share $ (0.19) $ (0.12) $ (0.43) $ (0.32)
Weighted average common shares, basic 13,785,657 11,230,525 13,000,211 10,996,996
Weighted average common shares, diluted 13,785,657 11,230,525 13,000,211 10,996,996